-60%

est. 2Y upside i

Healthcare

Rank

#4056

Sector

Healthcare Technology

Est. Liquidity

~5Y

Data Quality

Data: High

NeueHealth presents a risky equity opportunity for a job seeker.

Last updated: March 10, 2026

Bull (10%)+100%

Under NEA's strategic guidance and capital injection, NeueHealth successfully executes a turnaround, returning to strong double-digit revenue growth by leveraging its NeuePulse platform and integrated care model in the expanding value-based care market. This drives a valuation of approximately $2.93 billion within 2-3 years, representing a 2x return on the acquisition price.

Base (30%)+20%

NeueHealth achieves modest operational improvements and stabilizes its revenue, but growth remains slow due to intense competition and regulatory complexities. The company maintains its market position but struggles to significantly expand, leading to a valuation of around $1.76 billion, a slight increase from the acquisition price.

Bear (60%)-40%

NeueHealth fails to reverse its negative growth trend, facing continued pressure from dominant incumbents and challenges in scaling its value-based care models. Despite NEA's backing, the company struggles to achieve consistent profitability, leading to a further write-down by investors and a valuation of approximately $0.88 billion, resulting in a significant loss for common equity holders.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

67%

Prior to the acquisition, the company raised $2.4 billion in total funding, significantly exceeding the $1.465 billion acquisition valuation, indicating that prior common shareholders likely received little to no value.

Dilution Risk

high

As a privately held company under private equity ownership, future dilution risk exists depending on NEA's capital allocation strategy and any subsequent funding rounds.

Secondary Liquidity

none

NeueHealth is now a privately held company, and its stock ceased trading on the NYSE, meaning there is no active public market for employee equity.

Other — 2 roles

View all 2 open roles at NeueHealth →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on NeueHealth's data — designed to show you've done your homework.

  • 1

    “Given the recent acquisition by NEA, how does NeueHealth plan to leverage NEA's resources and expertise to accelerate growth and achieve sustainable profitability in the next 2-3 years, especially considering the negative revenue growth in 2025?”

  • 2

    “NeueHealth operates in a highly competitive market with dominant incumbents like UnitedHealth Group and Humana. What specific strategies are in place to differentiate NeueHealth's value proposition and protect its market share against these large players?”

  • 3

    “With the company now private under NEA, what is the expected timeline and potential exit strategy for employees holding equity, and how will future equity grants be structured to ensure alignment with long-term value creation?”

Community

Valuation Sentiment

Our model estimates -60% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.